Neutralizing IgG4 antibodies are a biomarker of sustained efficacy after peanut oral immunotherapy
Year: 2024
Type: article
Language: English
Subfield: Immunology and Allergy
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Massachusetts General Hospital, National Institutes of Health, National Institute of Allergy and Infectious Diseases, National Institute of Environmental Health Sciences, National Center for Research Resources, National Center for Advancing Translational Sciences, NHLBI Division of Intramural Research
Awards: G1470284823, G2056455923, Translational Immunology Core's FACSAria Cell Sorter, Harvard Clinical and Translational Science Center (UL1), Influx Flow Cytometer, ImageStream X Analyzer 2011, G5845357858, G6062993627, G6133285759, G690901646, Department of Pathology LSR2 Cytometer, G7295373465, G8282590464, Convergent allergen-specific antibodies in food allergy, Molecular Allergy, Crystallographic studies of macromolecular structures
OpenAlex ID: W4392563106
